Live Breaking News & Updates on Actemra

Stay informed with the latest breaking news from Actemra on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Actemra and stay connected to the pulse of your community

Roche Holding plans to sell 800-employee drug manufacturing plant in Vacaville

The company said it is seeking a buyer that will continue to use the plant as an operating facility.

Theresa-graham , Thomas-schinecker , Genentech , Regeneron-pharmaceuticals , Roche , Roche-news , Oche-holding , Avastin , Herceptin , Actemra ,

Biogen Announces EMA Acceptance Of Tocilizumab Biosimilar Application - Life Sciences, Biotechnology & Nanotechnology

Biogen Inc. ("Biogen") recently announced that the European Medicines Agency (EMA) has accepted the marketing authorization application for BIIB800 (BAT1806)...

China , Ian-henshaw , Bio-thera-solutions-ltd , European-medicines-agency , Biogen-inc , China-national-medical-products , Bio-thera-solutions , National-medical-products , Mondaq , Actemra , Io-thera-solutions , Iogen

Roche gets USFDA priority review for Actemra to treat Covid-19

Basel: Roche today announced that the U.S. Food and Drug Administration (USFDA) has accepted the company's supplemental Biologics License Application (sBLA) and has granted Priority Review for...

Honduras , Australia , Philippines , Japan , United-states , Hong-kong , United-kingdom , Bolivia , Ghana , Ecuador , Chile , Peru

Medicii britanici dau undă verde unui cocktail de anticorpi împotriva coronavirusului

Agenţia britanică pentru medicamente a aprobat vineri un cocktail de anticorpi produs de Regeneron şi Roche în scopul prevenirii şi tratării...

United-kingdom , Agency-united-kingdom , Doctors-united-kingdom , Experts-united-kingdom , May-states , Actemra , Anticorp , Covid-19 , Dexametazonă , Medicament , Regen-cov

唐獎得主開發藥物安挺樂 FDA緊急授權治療新冠病人 - 生活

2020年唐獎生技醫藥得主、日本大阪大學教授岸本忠三及其團隊與國際藥廠合作研發的IL-6受體抗體藥物，24日通過美國食藥署(FDA)通過緊急授權，將成為美國藥廠Genetech藥廠開發的安挺樂Actemra藥物，用以治療新冠病人。

United-states , Japan , Japan-osaka-university-professor-shore , Drug-agency-pass , United-states-food , Il , 唐獎 , Actemra , 藥物 , 安挺樂 , ஒன்றுபட்டது-மாநிலங்களில்

Govt should issue compulsory licences to boost covid drugs production: IDMA

Govt should issue compulsory licences to boost covid drugs production: IDMA
Premium
(AFP)
The Indian Drug Manufacturers’ Association (IDMA) on Wednesday urged the government to use provisions of the World Trade Organization (WTO) to issue compulsory licences to pharma firms to make drugs such as remdesivir that are used in the treatment of covid
Read Full Story
The Indian Drug Manufacturers’ Association (IDMA) on Wednesday urged the government to use provisions of the World Trade Organization (WTO) to issue compulsory licences to pharma firms to make drugs such as remdesivir that are used in the treatment of covid.
“WTO has also provided the provision of compulsory licensing just for tackling such an eventuality. Our government should not feel shy in invoking this in the interest of humanity and our citizens," IDMA said in a position paper on patent waivers.

World-trade-organization , Indian-drug-manufacturer-association , Idma , Drugmakers , Covid-19-drugs , Wto , Cipla , Actemra , Gilead-sciences , Sun-pharmaceutical , Pharma

Roche says adding Actemra to Gilead's remdesivir didn't cut COVID patient hospital stays

Roche says adding Actemra to Gilead's remdesivir didn't cut COVID patient hospital stays
yahoo.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from yahoo.com Daily Mail and Mail on Sunday newspapers.

Yahoo , Gilead-sciences , Actemra , Antiviral-drug , Roche , Cancer-patients , யாகூ , கிலியட்-அறிவியல் , ரோச் , புற்றுநோய்-நோயாளிகள் ,

Roche's arthritis drug Actemra scores FDA nod in rare autoimmune disease after partial clinical win

Mar 5, 2021 11:20am
Roche's Actemra has become the first biologic that the FDA approved for patients with systemic sclerosis-associated interstitial lung disease. (Roche/Genentech)
Missed the primary endpoint of a clinical trial? No problem. We’ll pick the study apart and approve your drug based on a post-hoc subgroup analysis.
That’s what the FDA did in granting Roche’s Actemra a go-ahead in patients with interstitial lung disease (ILD) associated with the rare autoimmune disease systemic sclerosis (SSc).
The approval makes Actemra the first biologic drug cleared by the FDA to slow the decline in pulmonary function in patients with SSc-ILD, Roche’s Genentech said Thursday.

Roche-actemra , Roche-genentech , National-institute-for-health-research , Uncover-rare-disease-insights , Accelerate-commercialization , Improve-patient , Rodnan-skin , Gilead-science , National-institute , Health-research , Roche , Actemra

The Latest: Florida urges more vaccine for its many seniors

COLOMBO, Sri Lanka — Sri Lanka is welcoming tourists again after keeping the doors...

Florida , United-states , Brazil , Sacramento , California , Oklahoma , Madrid , Spain , Pakistan , New-york , Georgia , United-kingdom

The Latest: Britain hits another record daily virus deaths

COLOMBO, Sri Lanka — Sri Lanka is welcoming tourists again after keeping the doors...

Spain , Portugal , Michigan , United-states , Seychelles , Poland , China , West-virginia , Afghanistan , United-kingdom , Paris , France-general